Five Prime Therapeutics: 3Q Earnings Snapshot
SOUTH SAN FRANCISCO, Calif. (AP) _ Five Prime Therapeutics Inc. (FPRX) on Wednesday reported a loss of $36.1 million in its third quarter.
The South San Francisco, California-based company said it had a loss of $1.03 per share.
The results missed Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 95 cents per share.
The biotech company that develops treatments targeting cancer and autoimmune diseases posted revenue of $3 million in the period, which also fell short of Street forecasts. Five analysts surveyed by Zacks expected $4.3 million.
In the final minutes of trading on Wednesday, the company’s shares hit $4.01. A year ago, they were trading at $12.11.